Profil
Arda M.
Minocherhomjee is the founder of Chicago Growth Partners LLC, serving as Partner since 2004.
Current jobs include Chairman at Elira, Inc., Director at EndoGastric Solutions, Inc., Director at Molecular Stethoscope, Inc., Director at Caprion Proteomics, Inc., Director at Jana Care, Inc., Independent Director at ReShape Weightloss, Inc. since 2018, Independent Director at ReShape Lifesciences, Inc. since 2018, and Senior Advisor at Healthxcapital SG Pte Ltd. Former jobs include Director at AtheroGenics, Inc., Director at Favrille, Inc. from 2004 to 2007, Director at NuVasive, Inc., Director & Managing Director at William Blair Capital Partners VII LP, Director at POINT Biomedical Corp., Director at Genoptix, Inc. from 2005 to 2009, Director at TargeGen, Inc., Director at Xoft, Inc., Independent Director at Zogenix, Inc. from 2012 to 2013, Director at Highridge Medical LLC, Director at Obalon Therapeutics, Inc., Managing Director at William Blair Capital Partners LLC, Director at Morton Grove Pharmaceuticals, Inc., Director at NovaVision, Inc., Director at Proteome, Inc., Director at PharmaResearch Corp, Director at CryoCor, Inc. from 2003 to 2008, Director & Managing Director at William Blair Capital Partners VI LLC, Director at Eramzac Management, Inc., Director at Cubic Wafer, Inc., Director at DJ Pharma, Inc., Director at CellCarta Biosciences, Inc., and Partner at William Blair & Co. Education includes an MBA and a doctorate from the University of British Columbia, and a graduate degree from the University of Toronto.
Postes actifs de Arda Minocherhomjee
| Sociétés | Poste | Début |
|---|---|---|
Chicago Growth Partners LLC
Chicago Growth Partners LLC Investment ManagersFinance Chicago Growth Partners invests in companies located in the United States. The firm focuses on companies operating in the fields of business & consumer services, healthcare products & services and industrial growth. It participates in buy-out, recapitalization, and founder liquidity transactions with an investment size of USD 15 – 75 million and takes majority and controlling interest. | Fondateur | 01/01/2004 |
EndoGastric Solutions, Inc.
EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology Manufactures and markets proprietary disposable medical devices | Directeur/Membre du Conseil | - |
ReShape Weightloss, Inc.
ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for the treatment of obesity | Directeur/Membre du Conseil | 13/08/2018 |
Elira, Inc.
Elira, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Président | - |
Jana Care, Inc.
Jana Care, Inc. Medical SpecialtiesHealth Technology Develops point-of-care diagnostic tools and digital platforms for chronic disease management | Directeur/Membre du Conseil | - |
Molecular Stethoscope, Inc.
Molecular Stethoscope, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostic and transcriptomic research services | Directeur/Membre du Conseil | - |
Healthxcapital SG Pte Ltd.
Healthxcapital SG Pte Ltd. Investment ManagersFinance HelathXCapital is an active manager which invests in healthcare companies based on South East Asia and India. The firm follows a multi sector approach concentrating on point of care diagnostics/devices, home health solutions, preventive health solutions, digital health solutions, biomarkers and AI/ML. The firm makes investments in early stage transactions. | Consultant / Advisor | - |
Anciens postes connus de Arda Minocherhomjee
| Sociétés | Poste | Fin |
|---|---|---|
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry | Directeur/Membre du Conseil | 07/01/2016 |
| ZOGENIX, INC. | Directeur/Membre du Conseil | 01/02/2013 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Arda Minocherhomjee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 34 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Favrille, Inc.
Favrille, Inc. Medical SpecialtiesHealth Technology Researches, develops and commercializes targeted immunotherapies for the treatment of cancer and diseases of the immune system | Health Technology |
NuVasive, Inc.
NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
William Blair Capital Partners VII LP
William Blair Capital Partners VII LP Investment ManagersFinance Acts as Private Equity Fund | Finance |
POINT Biomedical Corp.
POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology Develops biomedical-imaging products | Health Technology |
EndoGastric Solutions, Inc.
EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology Manufactures and markets proprietary disposable medical devices | Health Technology |
Genoptix, Inc.
Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Health Technology |
Xoft, Inc.
Xoft, Inc. Data Processing ServicesTechnology Services Provides electronic brachytherapy technology services | Technology Services |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
Lanx, Inc.
Lanx, Inc. Medical SpecialtiesHealth Technology Develops medical devices for spinal surgery | Health Technology |
Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical balloon technology for weight loss therapy | Health Technology |
William Blair Capital Partners LLC
William Blair Capital Partners LLC Investment ManagersFinance William Blair Capital Partners (WBCP) focuses on private placements, PIPES and the investment of funds provided by partners of the firm. They invest in the following sectors: business services, financial services, consumer, healthcare services, healthcare products and technology. Within the business and financial services sectors, WBCP focuses on accounts receivable management, asset management services, data analytics, distribution services, education/educational services, interactive media, niche consulting, payment processing, payroll processing, research products/services, specialty insurance products and specialized marketing services. WBCP seeks investments in outstanding growth companies in the consumer sector. The firm looks for companies that need capital to expand through organic growth, regional expansion or through acquisition of other market players. They focus primarily on two niches within the consumer segment: (1) companies involved in the sale of new and novel products and services to the consumer and companies involved in the sale of well-established products in new and novel ways. WBCP seeks to invest in growing, well-managed companies with strong management teams that are, or have the potential to become, leaders in their market niche. Within the healthcare sector, WBCP invests primarily in the medical devices, biopharmaceuticals and healthcare services industries. The firm looks for innovative companies with products that address unmet medical needs. They are particularly interested in therapeutic areas in which relatively little capital has been historically deployed, including gastroenterology, neurology/neurosurgery and cosmetic surgery and aesthetics. They may also consider investment opportunities in the orthopedic, spine and cardiovascular segments. In the biopharmaceutical industry, WBCP invests primarily in companies that have late-stage (phase II clinical trials or later) compounds or that have approved products. The firm also pursues opportunities to start and nurture pharmaceutical companies in the dermatology, neurology, rheumatology and gastroenterology specialties. WBCP also invests in small market companies with annual revenues of $50 million to $300 million that have not generated strong commercial or development interest from large pharmaceutical companies. WBCP considers investments in healthcare companies that provide services to patients in the outpatient or short-stay settings and in companies that provide outsourced business services to larger healthcare providers such as hospitals or surgery centers. The firm is particularly interested in service companies that pursue segments of the healthcare economy in which the patient pays directly for the service or that provide business-to-business services to healthcare providers. They also invest in companies that provide medical services to governmental healthcare programs such as Medicare and Medicaid. WBCP invests technology companies primarily in the following areas: wireless semiconductors, consumer electronic semiconductors/software, wireless Internet and software as service (SaaS). They firm seeks to invest in companies with (1) platform technology including core technology can be applied to multiple markets across multiple product lines (2) scaleable and capital efficient business models (3) market opportunities that have been validated by customers (4) disruptive technology that is non-disruptive to implement (5) a defensible and sustainable technology lead (6) multiple exit opportunities including acquisition and IPO and (7) compelling growth rates appropriate for their business model. WMCP invests in companies that require funds for product development, sales, marketing and operations. They do not invest in technology development. | Finance |
Morton Grove Pharmaceuticals, Inc.
Morton Grove Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets liquid pharmaceutical products | Health Technology |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services Provides vision restoration therapy services | Health Services |
Proteome, Inc.
Proteome, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and designs genomic database products and systems | Commercial Services |
PharmaResearch Corp
PharmaResearch Corp Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical development and research services | Commercial Services |
CryoCor, Inc.
CryoCor, Inc. Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
William Blair Capital Partners VI LLC | |
Eramzac Management, Inc.
Eramzac Management, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies medical products | Health Technology |
Chicago Growth Partners LLC
Chicago Growth Partners LLC Investment ManagersFinance Chicago Growth Partners invests in companies located in the United States. The firm focuses on companies operating in the fields of business & consumer services, healthcare products & services and industrial growth. It participates in buy-out, recapitalization, and founder liquidity transactions with an investment size of USD 15 – 75 million and takes majority and controlling interest. | Finance |
Cubic Wafer, Inc.
Cubic Wafer, Inc. SemiconductorsElectronic Technology Designs and develops integrated circuits | Electronic Technology |
DJ Pharma, Inc. | |
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as specialty contract research laboratory | Commercial Services |
William Blair & Co
William Blair & Co Investment Banks/BrokersFinance Provides investment banking and asset management services | Finance |
Elira, Inc.
Elira, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Molecular Stethoscope, Inc.
Molecular Stethoscope, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostic and transcriptomic research services | Health Services |
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry | Health Technology |
Jana Care, Inc.
Jana Care, Inc. Medical SpecialtiesHealth Technology Develops point-of-care diagnostic tools and digital platforms for chronic disease management | Health Technology |
ReShape Weightloss, Inc.
ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for the treatment of obesity | Health Technology |
Healthxcapital SG Pte Ltd.
Healthxcapital SG Pte Ltd. Investment ManagersFinance HelathXCapital is an active manager which invests in healthcare companies based on South East Asia and India. The firm follows a multi sector approach concentrating on point of care diagnostics/devices, home health solutions, preventive health solutions, digital health solutions, biomarkers and AI/ML. The firm makes investments in early stage transactions. | Finance |
ReShape Lifesciences, Inc.
ReShape Lifesciences, Inc. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of obesity | Health Technology |
















